Literature DB >> 19721007

Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression.

Andrea Paradisi1, Carine Maisse, Marie-May Coissieux, Nicolas Gadot, Florian Lépinasse, Céline Delloye-Bourgeois, Jean-Guy Delcros, Magali Svrcek, Clemens Neufert, Jean-François Fléjou, Jean-Yves Scoazec, Patrick Mehlen.   

Abstract

Chronic inflammation and cancer are intimately associated. This is particularly true for inflammatory bowel diseases (IBD), such as ulcerative colitis and Crohn's disease, which show a major increased risk for colorectal cancer. While the understanding of the molecular pathogenesis of IBD has recently improved, the mechanisms that link these chronic inflammatory states to colorectal cancer development are in large part unknown. One of these mechanisms is NF-kappaB pathway activation which in turn may contribute to tumor formation by providing anti-apoptotic survival signals to the epithelial cells. Based on the observation that netrin-1, the anti-apoptotic ligand for the dependence receptors DCC and UNC5H is up-regulated in colonic crypts in response to NF-kappaB, we show here that colorectal cancers from inflammatory bowel diseases patients have selected up-regulation of netrin-1. Moreover, we demonstrate that this inflammation-driven netrin-1 up-regulation is causal for colorectal cancer development as interference with netrin-1 autocrine loop in a mouse model for ulcerative colitis-associated colorectal cancer, while showing no effect on inflammation, inhibits colorectal cancer progression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19721007      PMCID: PMC2761333          DOI: 10.1073/pnas.0901767106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

Review 1.  Pathology of mouse models of intestinal cancer: consensus report and recommendations.

Authors:  Gregory P Boivin; Kay Washington; Kan Yang; Jerrold M Ward; Theresa P Pretlow; Robert Russell; David G Besselsen; Virginia L Godfrey; Tom Doetschman; William F Dove; Henry C Pitot; Richard B Halberg; Steven H Itzkowitz; Joanna Groden; Robert J Coffey
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

2.  The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation.

Authors:  C Forcet; X Ye; L Granger; V Corset; H Shin; D E Bredesen; P Mehlen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

3.  Integrin up-regulation in chronic liver disease: relationship with inflammation and fibrosis in chronic hepatitis C.

Authors:  M Nejjari; A Couvelard; J F Mosnier; A Moreau; G Feldmann; C Degott; P Marcellin; J Y Scoazec
Journal:  J Pathol       Date:  2001-11       Impact factor: 7.996

4.  Netrin-1 acts as a survival factor via its receptors UNC5H and DCC.

Authors:  F Llambi; F Causeret; E Bloch-Gallego; P Mehlen
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

5.  p53RDL1 regulates p53-dependent apoptosis.

Authors:  Chizu Tanikawa; Koichi Matsuda; Seisuke Fukuda; Yusuke Nakamura; Hirofumi Arakawa
Journal:  Nat Cell Biol       Date:  2003-03       Impact factor: 28.824

6.  IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer.

Authors:  Florian R Greten; Lars Eckmann; Tim F Greten; Jin Mo Park; Zhi-Wei Li; Laurence J Egan; Martin F Kagnoff; Michael Karin
Journal:  Cell       Date:  2004-08-06       Impact factor: 41.582

Review 7.  Cancer genes and the pathways they control.

Authors:  Bert Vogelstein; Kenneth W Kinzler
Journal:  Nat Med       Date:  2004-08       Impact factor: 53.440

8.  Interfering with multimerization of netrin-1 receptors triggers tumor cell death.

Authors:  F Mille; F Llambi; C Guix; C Delloye-Bourgeois; C Guenebeaud; S Castro-Obregon; D E Bredesen; C Thibert; P Mehlen
Journal:  Cell Death Differ       Date:  2009-06-19       Impact factor: 15.828

9.  The netrin-1 receptors UNC5H are putative tumor suppressors controlling cell death commitment.

Authors:  Karine Thiebault; Laetitia Mazelin; Laurent Pays; Fabien Llambi; Marie-Odile Joly; Jean-Yves Scoazec; Jean-Christophe Saurin; Giovanni Romeo; Patrick Mehlen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-24       Impact factor: 11.205

10.  Netrin-1 acts as a survival factor for aggressive neuroblastoma.

Authors:  Céline Delloye-Bourgeois; Julien Fitamant; Andrea Paradisi; David Cappellen; Setha Douc-Rasy; Marie-Anne Raquin; Dwayne Stupack; Akira Nakagawara; Raphaël Rousseau; Valérie Combaret; Alain Puisieux; Dominique Valteau-Couanet; Jean Bénard; Agnès Bernet; Patrick Mehlen
Journal:  J Exp Med       Date:  2009-04-06       Impact factor: 14.307

View more
  43 in total

1.  Deleted in Colorectal Cancer (DCC) pathfinding: axon guidance gene finally turned tumor suppressor.

Authors:  Molly Duman-Scheel
Journal:  Curr Drug Targets       Date:  2012-10       Impact factor: 3.465

Review 2.  Murine Model for Colitis-Associated Cancer of the Colon.

Authors:  Ashley J Snider; Agnieszka B Bialkowska; Amr M Ghaleb; Vincent W Yang; Lina M Obeid; Yusuf A Hannun
Journal:  Methods Mol Biol       Date:  2016

3.  Netrin-1 induces epithelial-mesenchymal transition and promotes hepatocellular carcinoma invasiveness.

Authors:  Wei Yan; Ping Han; Zhenzhen Zhou; Wei Tu; Jiazhi Liao; Peiyuan Li; Mei Liu; Dean Tian; Yu Fu
Journal:  Dig Dis Sci       Date:  2014-01-18       Impact factor: 3.199

4.  Blocking SHH/Patched Interaction Triggers Tumor Growth Inhibition through Patched-Induced Apoptosis.

Authors:  Patrick Mehlen; Joanna Fombonne; Pierre-Antoine Bissey; Pauline Mathot; Catherine Guix; Mélissa Jasmin; Isabelle Goddard; Clélia Costechareyre; Nicolas Gadot; Jean-Guy Delcros; Sachitanand M Mali; Rudi Fasan; André-Patrick Arrigo; Robert Dante; Gabriel Ichim
Journal:  Cancer Res       Date:  2020-02-14       Impact factor: 12.701

Review 5.  Colorectal Cancer in Inflammatory Bowel Disease.

Authors:  Ryan W Stidham; Peter D R Higgins
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01

6.  Role of Netrin-1 Beyond the Brain: From Biomarker of Tissue Injury to Therapy for Inflammatory Diseases.

Authors:  Ganesan Ramesh
Journal:  Recent Pat Biomark       Date:  2012-09

7.  PKCα is involved in the progression of kidney carcinoma through regulating netrin-1/UNC5B signaling pathway.

Authors:  Bo Zhan; Chuize Kong; Kunfeng Guo; Zhe Zhang
Journal:  Tumour Biol       Date:  2013-03-23

8.  Netrin-1 regulates colon-kidney cross talk through suppression of IL-6 function in a mouse model of DSS-colitis.

Authors:  Punithavathi Ranganathan; Calpurnia Jayakumar; Manicassamy Santhakumar; Ganesan Ramesh
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-27

9.  Targeting Netrin-1 in glioblastoma stem-like cells inhibits growth, invasion, and angiogenesis.

Authors:  Tanwarat Sanvoranart; Aungkura Supokawej; Pakpoom Kheolamai; Yaowalak U-Pratya; Niphon Poungvarin; Sith Sathornsumetee; Surapol Issaragrisil
Journal:  Tumour Biol       Date:  2016-09-20

10.  TNF-α mediates macrophage-induced bystander effects through Netrin-1.

Authors:  Yonghong Yang; Xingmin Wang; Danny R Moore; Stanley A Lightfoot; Mark M Huycke
Journal:  Cancer Res       Date:  2012-08-22       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.